V029-3924 Screening compound: 3-(1-benzyl-1H-indol-3-yl)-3-(6-chloropyridin-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

V029-3924 Screening compound: 3-(1-benzyl-1H-indol-3-yl)-3-(6-chloropyridin-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide
V029-3924 Screening compound: 3-(1-benzyl-1H-indol-3-yl)-3-(6-chloropyridin-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-3924
3-(1-benzyl-1H-indol-3-yl)-3-(6-chloropyridin-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-3924

Molecular Formula

C29H31ClN4O2 (C29 H31 ClN4 O2)

Compound Name

3-(1-benzyl-1H-indol-3-yl)-3-(6-chloropyridin-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

IUPAC name

3-(1-benzyl-1H-indol-3-yl)-3-(6-chloropyridin-3-yl)-N-[2-(morpholin-4-yl)ethyl]propanamide

SMILES

O=C(CC(c1cn(Cc2ccccc2)c2c1cccc2)c(cc1)cnc1Cl)NCCN1CCOCC1

InChI

InChI=1S/C29H31ClN4O2/c30-28-11-10-23(19-32-28)25(18-29(35)31-12-13-33-14-16-36-17-15-33)26-21-34(20-22-6-2-1-3-7-22)27-9-5-4-8-24(26)27/h1-11,19,21,25H,12-18,20H2,(H,31,35)/t25-/m1/s1

InChI Key

RDSNBTGDSFUIEH-RUZDIDTESA-N

MDL Number (MFCD)

MFCD20493224

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

503.04

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.563

Distribution Coefficient, logD

3.487

Water Solubility, LogSw

-3.87

Polar Surface Area

46.636

Acid Dissociation Constant (pKa)

12.92

Base Dissociation Constant (pKb)

6.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.00

V029-3924 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V029-3924 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-3924?
Check Price and Availability of V029-3924, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-3924 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-3924
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-3924
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-3924 available by request